tiprankstipranks
Trending News
More News >
U.s. Physical Therapy (USPH)
NYSE:USPH
US Market
Advertisement

US Physical Therapy (USPH) Stock Forecast & Price Target

Compare
100 Followers
See the Price Targets and Ratings of:

USPH Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
Based on 6 analysts giving stock ratings to
US
Physical Therapy
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

USPH Stock 12 Month Forecast

Average Price Target

$100.50
▲(39.54% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for US Physical Therapy in the last 3 months. The average price target is $100.50 with a high forecast of $113.00 and a low forecast of $81.00. The average price target represents a 39.54% change from the last price of $72.02.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"$69","114":"$114","80.25":"$80.3","91.5":"$91.5","102.75":"$102.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":113,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$113.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":100.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$100.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":81,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$81.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,80.25,91.5,102.75,114],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.61,83.10153846153847,85.59307692307692,88.08461538461539,90.57615384615384,93.06769230769231,95.55923076923077,98.05076923076923,100.54230769230769,103.03384615384616,105.52538461538461,108.01692307692308,110.50846153846155,{"y":113,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.61,82.14,83.67,85.2,86.73,88.26,89.78999999999999,91.32,92.85,94.38,95.91,97.44,98.97,{"y":100.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.61,80.64,80.67,80.7,80.73,80.76,80.79,80.82,80.85,80.88,80.91,80.94,80.97,{"y":81,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":98.93,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.32,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.18,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.61,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.03,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.66,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.66,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.06,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.92,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.19,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$113.00Average Price Target$100.50Lowest Price Target$81.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on USPH
TipRanks AITipRanks
Not Ranked
TipRanks
$81
Hold
12.47%
Upside
Reiterated
07/31/25
US Physical Therapy's overall stock score is primarily bolstered by its solid financial performance and positive corporate events, indicating a stable outlook. However, mixed technical indicators and a high P/E ratio suggest caution. The earnings call adds a positive outlook, hinting at potential growth despite some challenges.
TR | OpenAI - 4o Analyst forecast on USPH
Rosa ClinessaTR | OpenAI - 4o
TR | OpenAI - 4o
$82$81
Hold
12.47%
Upside
Reiterated
07/31/25
Citizens JMP
$113
Buy
56.90%
Upside
Reiterated
07/25/25
Citizens JMP Sticks to Their Buy Rating for US Physical Therapy (USPH)Citizens JMP analyst Constantine Davides reiterated a Market Outperform rating and $113.00 price target on U.S. Physical Therapy (NYSE: USPH).
Barrington Analyst forecast on USPH
Michael PetuskyBarrington
Barrington
$98
Buy
36.07%
Upside
Reiterated
07/01/25
Positive Outlook for U.S. Physical Therapy Amid Medicare Policy Shifts and Strong Business Performance
Jefferies
$110
Buy
52.74%
Upside
Reiterated
05/22/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on USPH
Joanna GajukBank of America Securities
Bank of America Securities
Buy
Reiterated
05/16/25
US Physical Therapy (USPH) Gets a Buy from Bank of America Securities
William Blair Analyst forecast on USPH
Ryan DanielsWilliam Blair
William Blair
Hold
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: US Physical Therapy (NYSE: USPH) and Barinthus Biotherapeutics (NASDAQ: BRNS)
J.P. Morgan Analyst forecast on USPH
Lisa GillJ.P. Morgan
J.P. Morgan
$120$110
Buy
52.74%
Upside
Reiterated
03/19/25
U.S. Physical Therapy price target lowered to $110 from $120 at JPMorganU.S. Physical Therapy price target lowered to $110 from $120 at JPMorgan
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on USPH
TipRanks AITipRanks
Not Ranked
TipRanks
$81
Hold
12.47%
Upside
Reiterated
07/31/25
US Physical Therapy's overall stock score is primarily bolstered by its solid financial performance and positive corporate events, indicating a stable outlook. However, mixed technical indicators and a high P/E ratio suggest caution. The earnings call adds a positive outlook, hinting at potential growth despite some challenges.
TR | OpenAI - 4o Analyst forecast on USPH
Rosa ClinessaTR | OpenAI - 4o
TR | OpenAI - 4o
$82$81
Hold
12.47%
Upside
Reiterated
07/31/25
Citizens JMP
$113
Buy
56.90%
Upside
Reiterated
07/25/25
Citizens JMP Sticks to Their Buy Rating for US Physical Therapy (USPH)Citizens JMP analyst Constantine Davides reiterated a Market Outperform rating and $113.00 price target on U.S. Physical Therapy (NYSE: USPH).
Barrington Analyst forecast on USPH
Michael PetuskyBarrington
Barrington
$98
Buy
36.07%
Upside
Reiterated
07/01/25
Positive Outlook for U.S. Physical Therapy Amid Medicare Policy Shifts and Strong Business Performance
Jefferies
$110
Buy
52.74%
Upside
Reiterated
05/22/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on USPH
Joanna GajukBank of America Securities
Bank of America Securities
Buy
Reiterated
05/16/25
US Physical Therapy (USPH) Gets a Buy from Bank of America Securities
William Blair Analyst forecast on USPH
Ryan DanielsWilliam Blair
William Blair
Hold
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: US Physical Therapy (NYSE: USPH) and Barinthus Biotherapeutics (NASDAQ: BRNS)
J.P. Morgan Analyst forecast on USPH
Lisa GillJ.P. Morgan
J.P. Morgan
$120$110
Buy
52.74%
Upside
Reiterated
03/19/25
U.S. Physical Therapy price target lowered to $110 from $120 at JPMorganU.S. Physical Therapy price target lowered to $110 from $120 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering US Physical Therapy

1 Month
xxx
Success Rate
18/35 ratings generated profit
51%
Average Return
-0.83%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 51.43% of your transactions generating a profit, with an average return of -0.83% per trade.
3 Months
xxx
Success Rate
19/35 ratings generated profit
54%
Average Return
+4.35%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.29% of your transactions generating a profit, with an average return of +4.35% per trade.
1 Year
Michael PetuskyBarrington
Success Rate
16/35 ratings generated profit
46%
Average Return
+0.85%
reiterated a buy rating last month
Copying Michael Petusky's trades and holding each position for 1 Year would result in 45.71% of your transactions generating a profit, with an average return of +0.85% per trade.
2 Years
xxx
Success Rate
15/35 ratings generated profit
43%
Average Return
-2.45%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -2.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

USPH Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
1
1
1
1
Buy
5
4
8
9
12
Hold
3
4
6
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
15
15
19
In the current month, USPH has received 13 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. USPH average Analyst price target in the past 3 months is 100.50.
Each month's total comprises the sum of three months' worth of ratings.

USPH Financial Forecast

USPH Earnings Forecast

The previous quarter’s earnings for USPH were $0.81.
The previous quarter’s earnings for USPH were $0.81.

USPH Sales Forecast

The previous quarter’s earnings for USPH were $197.34M.
The previous quarter’s earnings for USPH were $197.34M.

USPH Stock Forecast FAQ

What is USPH’s average 12-month price target, according to analysts?
Based on analyst ratings, U.s. Physical Therapy’s 12-month average price target is 100.50.
    What is USPH’s upside potential, based on the analysts’ average price target?
    U.s. Physical Therapy has 39.54% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is USPH a Buy, Sell or Hold?
          U.s. Physical Therapy has a consensus rating of Moderate Buy which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
            What is U.s. Physical Therapy’s price target?
            The average price target for U.s. Physical Therapy is 100.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $113.00 ,the lowest forecast is $81.00. The average price target represents 39.54% Increase from the current price of $72.02.
              What do analysts say about U.s. Physical Therapy?
              U.s. Physical Therapy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of USPH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis